Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
During the 1st year after joining the Initiative, Poland has made a number of significant achievements. It conducted a very strong TAVI public campaign, participated in local symposia and the THT Congress also reaching the officials and other stakeholders. Thanks to Valve for Life (VFL) initiative, 2 registries are conducted in another participating country - France - in order to show the real number of patients requiring TAVI or mitral percutaneous treatment (MR) to the French Health Authority. After a successful launch of initiative, the 3rd country to join the initiative in 2017 is Portugal.
This initiative launched mid 2015 aims to improve transcatheter valve interventions (both aortic and mitral) across Europe in order to:
France has a limited number of reimbursed procedures (fixed to 7 000 per year by French Health Authority) as well as a limited number of implanting centres (only 50). Focus will be put on Transcatheter valvular heart disease interventions
Access the section dedicated to Valve for Life - France
Poland offers a government approved access but has limited funding is available for transcatheter heart valve therapies and a low penetration.
Access the section dedicated to Valve for Life - Poland
Portugal joined the initiative in January 2017 and was selected on the basis of a significant underuse of TAVI procedures when compared to other European countries and a very committed and well organized cardiology leadership in Portugal that can address the conduct of the initiative.
Access the section dedicated to Valve for Life - Portugal
Stephan Windecker, EAPCI Past-President 2016-2018Michael Haude, EAPCI President 2016-2018Andreas Baumbach, EAPCI President-Elect 2016-2018
Valve for Life Country Champions:
Dariusz Dudek, Valve for Life Poland Adam Witkowski, Valve for Life Poland Martine Gilard, Valve for Life FranceRui Campante Teles, Valve for Life Portugal Lino Patricio, Valve for Life Portugal
This initiative is supported since 2015 by Abbott and Edwards Lifesciences in the form of an unrestricted educational grant. They have no influence on the scientific content of the Initiative.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved